摘要
目的分析对未足月胎膜早破孕产妇使用硫酸镁联合盐酸利托君进行治疗的临床应用效果。方法选取2017年8月至2018年8月于本院进行治疗的未足月胎膜早破孕产妇86例作为研究对象,随机分为对照组和观察组,各43例。对照组采用硫酸镁进行治疗,观察组采用硫酸镁与盐酸利托君联合进行治疗,观察对比两组患者临床效果。结果两组患者分娩方式对比差异无统计学意义;观察组患者产后出血量显著少于对照组,观察组新生儿Apgar评分与出生体质量均明显优于对照组,组间对比差异具有统计学意义(P<0.05)。结论对未足月胎膜早破患者使用硫酸镁与盐酸利托君联合进行治疗,临床效果确切,可临床推广应用。
Objective To analyze the clinical bed effect of magnesium sulfate combined with ritodrine hydrochloride in the treatment of preterm premature rupture of membranes. Methods From August 2017 to August 2018, 86 pregnant women with preterm premature rupture of membranes who admitted to our hospital for treatment were selected as the study subjects. They were randomly divided into control group and observation group,with 43 cases in each group. The control group was treated with magnesium sulfate, while the observation group was treated with magnesium sulfate and ritodrine hydrochloride. The clinical effects of the two groups were observed and compared. Results There was no significant difference in delivery mode between the two groups. The amount of postpartum hemorrhage in the observation group was significantly less than that in the control group. The Apgar score and birth weight of the newborn in the observation group were significantly better than those in the control group, and there was significant difference between the two groups(P<0.05). Conclusion Magnesium sulfate combined with ritodrine hydrochloride is effective and can be widely used in the treatment of premature rupture of membranes.
作者
梁雨
丁兴琳
Liang Yu;Ding Xinglin(Department of Obstetrics and Gynecology,Jiujiang Maternal and Child Care Centres,Jiujiang,Jiangxi,332000,China)
出处
《当代医学》
2019年第33期48-50,共3页
Contemporary Medicine
关键词
未足月胎膜早破
硫酸镁
盐酸利托君
疗效
预后效果
Premature rupture of membranes before term
Magnesium sulfate
Ritojun hydrochloride
Therapeutic effect
Prognostic effect
